{"id":2568,"date":"2012-05-03T00:44:36","date_gmt":"2012-05-03T00:44:36","guid":{"rendered":"http:\/\/www.compumedics.com.au\/?p=2568"},"modified":"2016-11-23T00:45:19","modified_gmt":"2016-11-23T00:45:19","slug":"additional-1m-contract-in-china-underpins-key-growth-focus-on-emerging-markets-for-compumedics","status":"publish","type":"post","link":"https:\/\/www.compumedics.com.au\/en\/blog\/additional-1m-contract-in-china-underpins-key-growth-focus-on-emerging-markets-for-compumedics\/","title":{"rendered":"ADDITIONAL $1M CONTRACT IN CHINA UNDERPINS KEY GROWTH FOCUS ON EMERGING MARKETS FOR COMPUMEDICS"},"content":{"rendered":"<p><strong>Compumedics Limited (ASX: CMP) is pleased to announce the Company\u2019s Germany-based brain blood-flow ultrasonography division, Compumedics Germany GmbH (DWL), has secured new orders of approximately \u20ac0.75 million (\u2248AUD1.0 million) from Beijing Beike Digital Medical Technology (Beike) for the purchase of DWL\u00ae products.<\/strong><\/p>\n<p><strong>* Compumedics\u2019 Germany-based business, DWL, continues to expand its Chinese market presence<\/strong> <strong>booking another $1m (EUR750k) order<\/strong><\/p>\n<p><strong>* Compumedics Group sales to China increases momentum with FY2012 sales growth expected to be at least 40% over FY2011, <\/strong><strong>an increase over the 38% growth in sales to China achieved in FY2011<\/strong><\/p>\n<p><strong>* Compumedics has over a 20-year period become the premier supplier of China sleep, neurology and ultrasonic Doppler blood-flow monitoring systems, with an unsurpassed array of key-opinion-leader Compumedics\u2019 reference-centers<\/strong> <strong>now established across China and Hong Kong<\/strong><\/p>\n<p><strong>Compumedics Limited<\/strong> (ASX: CMP) is pleased to announce the Company\u2019s Germany-based brain blood-flow ultrasonography division, Compumedics Germany GmbH (DWL), has secured new orders of approximately \u20ac0.75 million (\u2248AUD1.0 million) from Beijing Beike Digital Medical Technology (Beike) for the purchase of DWL\u00ae products.<br \/>\nThis adds to the \u20ac0.6 million (\u2248AUD0.9 million) order received in early FY2012, bringing total business, for DWL, for the financial year-to-date to $1.7m (\u20ac1.3m) or a 37% increase, compared to the entire prior financial year. This milestone for Compumedics Germany continues to underpin the Compumedics Group\u2019s growing presence in China and is further evidence the Company\u2019s growth strategy of focusing on this growing market is well on track.<br \/>\nAs a result of the Group\u2019s successful and highly developed partnerships in China, Compumedics has achieved the following outcomes over the past 5 years, with significant momentum building over the last two years:<\/p>\n<ul class=\"bulletlist\">\n<li>Since FY2007 Group sales to China have almost tripled from USD1.8m to USD4.4m in FY2011<\/li>\n<li>Sales growth into China has gained momentum in the last two years with DWL sales growing 10% in FY2010 and a further 37% in Y2011 with FY2012 growth likely to be in excess of 37%, at this point in time<\/li>\n<li>Since FY2007 sales of Compumedics\u00ae sleep diagnostic systems have grown 400% from USD0.25m to USD1.0m in FY2011, providing an enormous opportunity for future growth given China\u2019s potential market size and its early phase of development<\/li>\n<li>Across the Asia region, including India, Compumedics has grown its sales from the region by about 11% per annum from USD4.5m in FY2007 to USD7.6m in FY2011<\/li>\n<li>Compumedics new neuro-diagnostic range of products, including the Neuvo\u00ae long-term EEG monitoring (LTEM) system, remains an untapped commercial opportunity in the region with initial sales forecast for FY2012.<\/li>\n<\/ul>\n<p>Compumedics remains focused on growing the Group through:<\/p>\n<ul class=\"bulletlist\">\n<li>Expansion of the Company\u2019s existing products into emerging markets particularly China; and<\/li>\n<li>Continuing the initial penetration of the neuro-diagnostic market, particularly the US, with Compumedics new range of neuro-diagnostic products, including the Neuvo\u00ae LTEM system<\/li>\n<\/ul>\n<p><strong>In commenting on the further boost to Compumedics\u2019 China business, Dr. David Burton, Chairman and CEO, said:<\/strong><\/p>\n<p>\u201cThese significant sales orders achieved through the course of the financial year further validate Compumedics\u2019 superior product offering, highlighting another important milestone for our Company. They reinforce our commitment to developing Compumedics\u2019 potential for exponential growth in the Asian markets, particularly in China.\u201d<\/p>\n<p>\u201cA recent study by the Shanghai Institution of Traditional Chinese Medicine for Sleep Disorders, published in the China Daily, estimates that up to 38% of the population of Shanghai suffers from some form of sleep disorder. In a city of 19 million people, this represents approximately 7 million potential sleep disorder patients who would greatly benefit from Compumedics\u2019 products.\u201d<\/p>\n<p>\u201cMarket research (Global Data 2010) confirms that Sleep Apnea Diagnostic Systems have been reported as the fastest growing category within the Chinese anaesthesia and respiratory devices market, with growth rates of 15.7 % between 2002 and 2009 and a forecast of 14.1% between 2009 and 2016. Importantly, in partnership with an extraordinary long-term network of existing distributors, Compumedics has established itself over the past 2 decades as the leading supplier of premier sleep and also neurology systems amongst the finest Chinese hospitals, universities and clinics, alike. Coupled with Compumedics\u2019 Australian headquarters ideal geographical positioning and global brand recognition built up over 25 years, we believe it is imperative that we investigate the potential to further strengthen our Chinese investment and trade prospects. The prospect of Compumedics further combining Chinese investment, manufacturing and engineering resources with Compumedics global market sleep and neurology technological and innovative leadership can provide a formidable expanded business opportunity and will be vigorously pursued.\u201d Dr. Burton added.<\/p>\n<p><strong>About Compumedics<\/strong><\/p>\n<p>Compumedics Limited was founded in <strong>1987<\/strong> by current Chairman\/CEO Dr. David Burton and today is a global leader in the design and manufacture of diagnostic technologies for sleep disorders, neurophysiology and cardiology. In <strong>1987<\/strong> Compumedics established Asia Pacific\u2019s first fully computerized sleep laboratory. Compumedics holds 80% share of the Australian sleep-diagnostic market, and has a major and rapidly growing presence in the US, European and Asian marketplaces for its sleep, neurological and Doppler blood-flow diagnostic monitoring devices. In <strong>1995<\/strong> the company was selected to supply equipment to the US Sleep Heart Health Study, the world\u2019s largest sleep study of its kind, with over 8,000 participants scheduled by 2008. With headquarters in Melbourne, Australia and offices in the United States, and Europe its products are distributed in over 50 countries. In <strong>1998<\/strong> Compumedics was awarded the overall Australian Exporter of the Year. In <strong>2000<\/strong>Compumedics was listed on the Australian Stock Exchange. In <strong>2002<\/strong>, Compumedics acquired US-based Neuroscan \u2013 the world\u2019s leading supplier of instruments for brain research. In the US \u2013 the world\u2019s largest medical device market \u2013 Neuroscan holds around 90% of the market for brain-research products. In <strong>2003<\/strong> Compumedics was awarded the Frost &amp; Sullivan Award for Market Expansion Strategy. In <strong>2004<\/strong>, Compumedics acquired Germany-based DWL Elektronishe GmbH, enabling Compumedics to expand its global operations into the neurovascular and cardio-vascular diagnostic fields. In<strong>2006<\/strong>, Compumedics was awarded the Frost and Sullivan Technology Leadership award for its innovative Somt\u00e9\u00ae recorder product. In <strong>2007<\/strong>, Compumedics and its Chairman were inducted into the Victorian Manufacturing Hall of Fame. In 2008 the DWL division received a top 100 German Innovation award. With 20,000 systems installed globally across the finest hospital, universities and clinics Compumedics sales have grown more than 4-fold from $9 million (1999) to $39 million (2008). In <strong>2009<\/strong> Compumedics was awarded a design award for its GRAEL\u00ae PSG\/EEG premium laboratory-based product. In<strong>2010<\/strong> Compumedics was recognized by the Australian Innovation Government and Industry body as one of Australia\u2019s Top 100 Health Innovators through its\u2019 world leading devices for sleep diagnostics.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Compumedics Limited (ASX: CMP) is pleased to announce the Company\u2019s Germany-based brain blood-flow ultrasonography division, Compumedics Germany GmbH (DWL), has secured new orders of approximately \u20ac0.75 million (\u2248AUD1.0 million) from Beijing Beike Digital Medical Technology (Beike) for the purchase of [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[98],"tags":[],"class_list":["post-2568","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/posts\/2568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/comments?post=2568"}],"version-history":[{"count":0,"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/posts\/2568\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/media?parent=2568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/categories?post=2568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.compumedics.com.au\/en\/wp-json\/wp\/v2\/tags?post=2568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}